APUS 8-K: Material agreement

Apimeds Pharmaceuticals US, Inc.

Filed with the SEC on · accession 0001213900-26-122743

APUS filed a 8-K (current report) with the SEC on Nov 20, 2026. Apimeds Pharmaceuticals US, Inc. entered into Amendment No. 1 to its Assignment and Transfer Agreement with FreeT Inc., clarifying consideration for Apitox-related rights. The stock moved -10.5% by the first close after the filing.

Summary of the filing

Apimeds Pharmaceuticals US, Inc. entered into Amendment No. 1 to its Assignment and Transfer Agreement with FreeT Inc., clarifying consideration for Apitox-related rights. The Company will issue 350,000 unregistered shares of common stock to FreeT by December 1, 2026, with potential additional payment based on an independent third-party valuation.

Key details

Initial payment in shares of common stock$350K
Registrant/issuerApimeds Pharmaceuticals US, Inc.
Counterparty/assigneeFreeT Inc.
Co-chief executive officerDr. Vin Menon
Co-chief executive officerSungJoon Chae

How APUS stock reacted

Close before

$1.74

Nov 19, 2026

First close after

-10.49%

$1.56

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for APUS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for APUS?

Click here

Frequently asked questions

What did APUS file with the SEC on Nov 20, 2026?

APUS filed a 8-K (Material agreement). Apimeds Pharmaceuticals US, Inc. entered into Amendment No. 1 to its Assignment and Transfer Agreement with FreeT Inc., clarifying consideration for Apitox-related rights. The Company will issue 350,000 unregistered shares of common stock to FreeT by December 1, 2026, with potential additional payment based on an independent third-party valuation.

What does a material agreement mean for APUS stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did APUS stock react to this filing?

APUS closed at $1.74 before the filing and $1.56 on Nov 20, 2026 (-10.49%).

Other APUS SEC filings

Get alerts when APUS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days